Lataa...
Minimally invasive local therapies for liver cancer
Primary and metastatic liver tumors are an increasing global health problem, with hepatocellular carcinoma (HCC) now being the third leading cause of cancer-related mortality worldwide. Systemic treatment options for HCC remain limited, with Sorafenib as the only prospectively validated agent shown...
Tallennettuna:
| Julkaisussa: | Cancer Biol Med |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Chinese Anti-Cancer Association
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4296086/ https://ncbi.nlm.nih.gov/pubmed/25610708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7497/j.issn.2095-3941.2014.04.001 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|